Can survivin expression predict the response to bortezomib in cases with mantle cell lymphoma?
Paydas
Semra
S
D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000378:metabolism*; D008869:Microtubule-Associated Proteins / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism*; D011719:Pyrazines / Q000627:therapeutic use*; D000077022:Survivin
C107489:BIRC5 protein, human; D001897:Boronic Acids; D051034:Inhibitor of Apoptosis Proteins; D008869:Microtubule-Associated Proteins; D016328:NF-kappa B; D009363:Neoplasm Proteins; D011719:Pyrazines; D000077022:Survivin; D000069286:Bortezomib